Nev. Rev. Stat. » NRS: CHAPTER 439B - RESTRAINING COSTS OF HEALTH CARE
Nevada Revised Statutes

Nev. Rev. Stat. § 439B.650 (2026)

Authority to compile annual report concerning price of certain drugs; contents of report; presentation of report at public hearing

✓ current as of July 2026
Find cases: SyfertCases citing this section NRSleg.state.nv.us (official) Justiaon Justia CornellLII Search CasesGoogle Scholar
NRS 439B.650  Authority to compile annual report concerning price of certain drugs; contents of report; presentation of report at public hearing.  On or before June 1 of each year, the Authority shall:

      1.  Analyze the information submitted pursuant to NRS 439B.635 to 439B.645, inclusive, and compile a report on the price of prescription drugs. The report:

      (a) Must include, without limitation, a separate analysis of the information reported by manufacturers, pharmacy benefit managers and wholesalers, the reasons for any increases in the prices of prescription drugs in this State and the effect of those prices on overall spending on prescription drugs, insurance premiums and cost-sharing in this State; and

      (b) May include, without limitation, opportunities for persons and entities in this State to lower the cost of prescription drugs while maintaining access to such drugs.

      2.  Present the findings in the report at a public hearing.

      (Added to NRS by 2017, 4299; A 2019, 1465; 2021, 3727; 2025, 3706)

     

Notes of Decisions
Cited in 1 case (1 in the last 5 years), 2022–2022 · leading case: The Nevada Indep. v. Whitley, 2022 NV 15 (Nev. 2022).
Sort: Relevance Newest Treatment
The Nevada Indep. v. Whitley, 2022 NV 15 (Nev. 2022). · cites it 6× “740 requires DHHS to include only aggregated data that does not disclose the identity of any manufacturer or PBM in its public reports submitted pursuant to NRS 439B.650 and descriptions of trends in prescription drugs and how those prices affect the prevalence and severity of…”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.